Biologically active proteins measured in the blood.
Interpretation of elevated cardiac biomarkers are evaluated in relation to their clinical context and not in isolation.
Complementary tools utilized with clinical evaluation.
Subdivided into 4 major categories: relation to cardiac injury, inflammation, hemodynamic stress and thrombosis. The
Value depends on accuracy, reproducibility and discrimination separating pathological limit abnormalities from normal findings, sensitivity, specificity for specific organ damage, and that the consequences of an elevated level.
Release of cardiac biomarkers indicate an ongoing pathological process in the heart.
Elevated levels of cardiac biomarker components indicates cardiac injury with myocardial cell death.
Blood levels of circulating endothelial cells may help predict impeding myocardial infarction, as they may indicator of arterial injury.